Virtus ETF Advisers LLC Deciphera Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $47,027 - $60,117	3,463 Added 16.81%	24,069 $378,000
Q4 2023 Feb 15, 2024	SELL	$10.11 - $16.54 $8,633 - $14,125	-854 Reduced 3.98%	20,606 $332,000
Q3 2023 Nov 07, 2023	SELL	$12.46 - $15.48 $34,551 - $42,926	-2,773 Reduced 11.44%	21,460 $272,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $64,275 - $77,246	4,840 Added 24.96%	24,233 $341,000
Q1 2023 May 15, 2023	BUY	$14.26 - $22.1 $4,862 - $7,536	341 Added 1.79%	19,393 $299,000
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $39,976 - $51,255	-2,692 Reduced 12.38%	19,052 $312,000
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $3,924 - $6,412	317 Added 1.48%	21,744 $402,000
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $195,199 - $299,549	21,427 New	21,427 $282,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $97,682 - $471,031	-12,686 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.46 - $37.15 $30,693 - $43,094	-1,160 Reduced 8.38%	12,686 $431,000
Q2 2021 Aug 10, 2021	BUY	$32.73 - $47.95 $93,836 - $137,472	2,867 Added 26.11%	13,846 $507,000
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $12,036 - $16,905	298 Added 2.79%	10,979 $492,000
Q4 2020 Feb 12, 2021	BUY	$51.77 - $66.18 $259,005 - $331,098	5,003 Added 88.11%	10,681 $610,000
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $34,207 - $45,422	-781 Reduced 12.09%	5,678 $291,000
Q2 2020 Aug 05, 2020	BUY	$37.05 - $65.03 $32,863 - $57,681	887 Added 15.92%	6,459 $386,000
Q1 2020 May 14, 2020	SELL	$33.63 - $69.4 $26,870 - $55,450	-799 Reduced 12.54%	5,572 $229,000
Q4 2019 Feb 13, 2020	SELL	$31.7 - $69.93 $171,877 - $379,160	-5,422 Reduced 45.98%	6,371 $397,000
Q3 2019 Nov 12, 2019	SELL	$19.95 - $38.85 $13,087 - $25,485	-656 Reduced 5.27%	11,793 $400,000
Q2 2019 Aug 13, 2019	BUY	$21.05 - $26.21 $39,384 - $49,038	1,871 Added 17.69%	12,449 $281,000
Q1 2019 May 14, 2019	SELL	$20.65 - $29.55 $24,676 - $35,312	-1,195 Reduced 10.15%	10,578 $246,000
Q4 2018 Feb 05, 2019	BUY	$19.08 - $36.14 $6,773 - $12,829	355 Added 3.11%	11,773 $247,000
Q3 2018 Nov 14, 2018	SELL	$33.57 - $42.1 $281,215 - $352,671	-8,377 Reduced 42.32%	11,418 $442,000
Q2 2018 Aug 10, 2018	BUY	$20.06 - $44.95 $397,087 - $889,785	19,795 New	19,795 $779,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account